[ Mon, Sep 30th 2024 ]: WOPRAI
[ Mon, Sep 30th 2024 ]: WOPRAI
[ Mon, Sep 30th 2024 ]: WOPRAI
[ Mon, Sep 30th 2024 ]: WOPRAI
[ Mon, Sep 30th 2024 ]: WOPRAI
[ Mon, Sep 30th 2024 ]: WOPRAI
[ Mon, Sep 30th 2024 ]: WOPRAI
[ Mon, Sep 30th 2024 ]: WOPRAI
[ Mon, Sep 30th 2024 ]: WOPRAI
[ Mon, Sep 30th 2024 ]: WOPRAI
[ Mon, Sep 30th 2024 ]: WOPRAI
[ Mon, Sep 30th 2024 ]: WOPRAI
[ Mon, Sep 30th 2024 ]: WOPRAI
[ Mon, Sep 30th 2024 ]: WOPRAI
[ Mon, Sep 30th 2024 ]: WOPRAI
[ Mon, Sep 30th 2024 ]: WOPRAI
[ Mon, Sep 30th 2024 ]: WOPRAI
[ Mon, Sep 30th 2024 ]: WOPRAI
[ Mon, Sep 30th 2024 ]: WOPRAI
[ Mon, Sep 30th 2024 ]: WOPRAI
[ Mon, Sep 30th 2024 ]: WOPRAI
[ Mon, Sep 30th 2024 ]: WOPRAI
[ Mon, Sep 30th 2024 ]: WOPRAI
[ Mon, Sep 30th 2024 ]: WOPRAI
[ Mon, Sep 30th 2024 ]: WOPRAI
[ Mon, Sep 30th 2024 ]: WOPRAI
[ Mon, Sep 30th 2024 ]: WOPRAI
[ Mon, Sep 30th 2024 ]: WOPRAI
[ Mon, Sep 30th 2024 ]: WOPRAI
[ Mon, Sep 30th 2024 ]: WOPRAI
[ Mon, Sep 30th 2024 ]: WOPRAI
[ Mon, Sep 30th 2024 ]: WOPRAI
[ Mon, Sep 30th 2024 ]: WOPRAI
[ Mon, Sep 30th 2024 ]: WOPRAI
[ Mon, Sep 30th 2024 ]: WOPRAI
[ Mon, Sep 30th 2024 ]: WOPRAI
[ Mon, Sep 30th 2024 ]: WOPRAI
[ Mon, Sep 30th 2024 ]: WOPRAI
[ Mon, Sep 30th 2024 ]: WOPRAI
[ Mon, Sep 30th 2024 ]: WOPRAI
[ Mon, Sep 30th 2024 ]: WOPRAI
[ Mon, Sep 30th 2024 ]: WOPRAI
[ Mon, Sep 30th 2024 ]: WOPRAI
[ Mon, Sep 30th 2024 ]: WOPRAI
[ Mon, Sep 30th 2024 ]: WOPRAI
[ Mon, Sep 30th 2024 ]: WOPRAI
[ Mon, Sep 30th 2024 ]: WOPRAI
[ Mon, Sep 30th 2024 ]: WOPRAI
Silvan Tuerkcan Reiterated (BNTC) at Buy and Held Target at $16 on, Sep 30th, 2024
- 🞛 This publication is a summary or evaluation of another publication
Silvan Tuerkcan of JMP Securities, Reiterated "Benitec Biopharma Inc." (BNTC) at Buy and Held Target at $16 on, Sep 30th, 2024.
Silvan has made no other calls on BNTC in the last 4 months.
There are 3 other peers that have a rating on BNTC. Out of the 3 peers that are also analyzing BNTC, 0 agree with Silvan's Rating of Hold.
These are the ratings of the 3 analyists that currently disagree with Silvan
- Debjit Chattopadhyay of "Guggenheim" Initiated at Strong Buy and Held Target at $17 on, Thursday, September 12th, 2024
- Mani Foroohar of "Leerink Partners" Initiated at Buy and Held Target at $13 on, Monday, July 22nd, 2024
- Yasmeen Rahimi of "Piper Sandler" Initiated at Buy and Held Target at $30 on, Thursday, June 13th, 2024